Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Stoke Therapeutics, Inc. (NASDAQ: STOK)
STOK Stock Predictions and Ratings
WSX Rating:
STRONG BUY
WSX Forecast (1yr):
35.10%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
26.70%
STOK Stock Analysis
STOK
PE Ratio:
STOK
PEG Ratio:
Not Available
STOK
Forward EPS Growth (12 month):
0.00%
STOK
PS Ratio:
57.2
STOK
PSG Ratio:
0.9
STOK
Forward Revenue Growth (12 month):
60.30%
STOK Articles
No data was found